81 related articles for article (PubMed ID: 8105201)
1. Thrombin generation after fast or prolonged regimens of tissue-type plasminogen activator.
Andreotti F; Kluft C; Hackett DR; Davies GJ; Maseri A
Lancet; 1993 Oct; 342(8876):937-8. PubMed ID: 8105201
[No Abstract] [Full Text] [Related]
2. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.
Gulba DC; Barthels M; Westhoff-Bleck M; Jost S; Rafflenbeul W; Daniel WG; Hecker H; Lichtlen PR
Circulation; 1991 Mar; 83(3):937-44. PubMed ID: 1900225
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
Merlini PA; Bauer KA; Oltrona L; Ardissino D; Spinola A; Cattaneo M; Broccolino M; Mannucci PM; Rosenberg RD
J Am Coll Cardiol; 1995 Jan; 25(1):203-9. PubMed ID: 7798503
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation during infusion of tissue-type plasminogen activator.
Genser N; Mair J; Maier J; Dienstl F; Puschendorf B; Lechleitner P
Lancet; 1993 Apr; 341(8851):1038. PubMed ID: 8096940
[No Abstract] [Full Text] [Related]
5. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
[TBL] [Abstract][Full Text] [Related]
6. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
[TBL] [Abstract][Full Text] [Related]
7. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
Wang Y; Liu Q; Zhu J; Yuan Z; Ma X
Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883
[TBL] [Abstract][Full Text] [Related]
8. Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease.
Pedersen OD; Gram J; Jespersen J
Heart; 1997 Feb; 77(2):122-7. PubMed ID: 9068393
[TBL] [Abstract][Full Text] [Related]
9. Persistent generation of thrombin after acute myocardial infarction.
Szczeklik A; Dropinski J; Radwan J; Krzanowski M
Arterioscler Thromb; 1992 May; 12(5):548-53. PubMed ID: 1576116
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and myocardial infarction during infusion of tissue-plasminogen activator.
Baglin TP; Luddington R; Jennings I; Richards EM
Lancet; 1993 Feb; 341(8843):504-5. PubMed ID: 8094535
[No Abstract] [Full Text] [Related]
11. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
12. Augmented plasma protein C activity after coronary thrombolysis with urokinase in patients with acute myocardial infarction.
Goto S; Handa S; Kawai Y; Watanabe K; Abe S; Takahashi E; Hori S; Ikeda Y
Cardiology; 1992; 80(3-4):252-6. PubMed ID: 1387346
[TBL] [Abstract][Full Text] [Related]
13. [May (must?) in a for recurrent thrombophlebitis [with normal AT III/ protein C+S] fully "marcumarized" patient (with [otherwise?] negative contraindications) with acute posterior wall infarct (15 min "old") a brief lysis therapy be instituted?].
Seitz R
Internist (Berl); 1995 Dec; 36(12):1202. PubMed ID: 8567228
[No Abstract] [Full Text] [Related]
14. Increased thrombin generation in women with recurrent miscarriage.
Vincent T; Rai R; Regan L; Cohen H
Lancet; 1998 Jul; 352(9122):116. PubMed ID: 9672284
[No Abstract] [Full Text] [Related]
15. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
16. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction.
Huisse MG; Ajzenberg N; Feldman L; Guillin MC; Steg PG
Thromb Haemost; 2009 Apr; 101(4):734-40. PubMed ID: 19350119
[TBL] [Abstract][Full Text] [Related]
17. Thrombin/antithrombin-III complex level as early predictor of reocclusion after successful thrombolysis.
Gulba DC; Barthels M; Reil GH; Lichtlen PR
Lancet; 1988 Jul; 2(8602):97. PubMed ID: 2898711
[No Abstract] [Full Text] [Related]
18. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
Johnson TJ
S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948
[No Abstract] [Full Text] [Related]
19. Prolonged coagulation instability is associated with a higher-dose regimen of tissue-type plasminogen activator in patients with acute myocardial infarction.
Andreotti F; Kluft C; Davies GJ; Hackett DR; Prevost R; Maseri A
Ann N Y Acad Sci; 1992 Dec; 667():450-3. PubMed ID: 1309068
[No Abstract] [Full Text] [Related]
20. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
